Skeletal uptake of diphosphonate: a review
- PMID: 7007051
- DOI: 10.1007/BF00252034
Skeletal uptake of diphosphonate: a review
Abstract
The diphosphonates are currently the skeletal imaging agents of choice and while extremely sensitive for bony abnormality their mechanism of action remains poorly understood. The current concepts in bone uptake mechanisms are reviewed and it is concluded that diphosphonate uptake is most likely related to sites of newly forming bone with diphosphonate adsorbed onto the surface of hydroxyapatite crystals. In situations where there is markedly increased skeletal uptake of tracer, increased vascularity alone cannot account for changes in tracer uptake and changes in skeletal extraction, related to newly forming bone are more important.
Similar articles
-
The role of skeletal blood flow in determining the uptake of 99mTc-methylene diphosphonate.Calcif Tissue Int. 1983 Jul;35(4-5):508-11. doi: 10.1007/BF02405085. Calcif Tissue Int. 1983. PMID: 6225500
-
[Local blood flow and bone uptake of methylene-diphosphonate-technetium-99m. 2].Boll Soc Ital Biol Sper. 1983 Nov 30;59(11):1614-7. Boll Soc Ital Biol Sper. 1983. PMID: 6230088 Italian. No abstract available.
-
Kinetics of 99mTc-tin-methylene diphosphonate in normal subjects and pathological conditions: a simple index of bone metabolism.Calcif Tissue Int. 1981;33(5):555. Calcif Tissue Int. 1981. PMID: 6797708 No abstract available.
-
Bone scan in metabolic bone diseases. Review.Nucl Med Rev Cent East Eur. 2012 Aug 25;15(2):124-31. Nucl Med Rev Cent East Eur. 2012. PMID: 22936506 Review.
-
24 hour whole body retention of 99mTc-methylene-diphosphonate in the assessment of bone formation. Methodological evaluation, clinical applications and comparison with serum alkaline phosphatase and serum osteocalcin.Dan Med Bull. 1989 Sep;36(4):349-58. Dan Med Bull. 1989. PMID: 2509145 Review. No abstract available.
Cited by
-
FDG-PET and CT patterns of bone metastases and their relationship to previously administered anti-cancer therapy.Eur J Nucl Med Mol Imaging. 2006 Nov;33(11):1280-4. doi: 10.1007/s00259-006-0141-3. Epub 2006 Jun 22. Eur J Nucl Med Mol Imaging. 2006. PMID: 16791597 Clinical Trial.
-
Diphosphonates in the evaluation of metabolic bone disease.Clin Rheumatol. 1982 Mar;1(1):41-4. doi: 10.1007/BF02032475. Clin Rheumatol. 1982. PMID: 6236012
-
Frequency of discordance between facet joint activity on technetium Tc99m methylene diphosphonate SPECT/CT and selection for percutaneous treatment at a large multispecialty institution.AJNR Am J Neuroradiol. 2014 Mar;35(3):609-14. doi: 10.3174/ajnr.A3731. Epub 2013 Sep 12. AJNR Am J Neuroradiol. 2014. PMID: 24029387 Free PMC article.
-
[68Ga]PSMA-HBED-CC Uptake in Osteolytic, Osteoblastic, and Bone Marrow Metastases of Prostate Cancer Patients.Mol Imaging Biol. 2017 Dec;19(6):933-943. doi: 10.1007/s11307-017-1101-y. Mol Imaging Biol. 2017. PMID: 28707038
-
Comparison of facet joint activity on 99mTc-MDP SPECT/CT with facet joint signal change on MRI with fat suppression.Diagn Interv Radiol. 2016 May-Jun;22(3):277-83. doi: 10.5152/dir.2015.15203. Diagn Interv Radiol. 2016. PMID: 27035592 Free PMC article.